Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride Patent Expiration
Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride is Used for treating allergic rhinitis, respiratory allergies, nasal swelling, sinus congestion, and pressure in adults and children aged 12 and older. It was first introduced by Chattem Inc Dba Sanofi Consumer Healthcare
Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride Patents
Given below is the list of patents protecting Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Allegra-d 24 Hour Allergy And Congestion | US6613357 | Osmotic device containing pseudoephedrine and an H1 antagonist |
Dec 25, 2020
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion | US6039974 | Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
Jul 31, 2018
(Expired) | Chattem Sanofi |
Allegra-d 24 Hour Allergy And Congestion | USRE39069 | Multi-layered osmotic device |
May 29, 2018
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
Allegra-d 24 Hour Allergy And Congestion |
US6037353 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Sep 14, 2017
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
Allegra-d 24 Hour Allergy And Congestion | US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
Mar 14, 2017
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion |
US5855912 (Pediatric) | Pharmaceutical compositions for piperidinalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion |
US6113942 (Pediatric) | Pharmaceutical composition for piperidinoalkanol compounds |
Aug 28, 2015
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion | US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion | US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
Feb 28, 2015
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion |
US7135571 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
Allegra-d 24 Hour Allergy And Congestion |
US7138524 (Pediatric) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
Nov 18, 2014
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
Allegra-d 24 Hour Allergy And Congestion |
US5578610 (Pediatric) | Piperidine derivatives |
May 26, 2014
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion | US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
Allegra-d 24 Hour Allergy And Congestion | US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
May 18, 2014
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
Allegra-d 24 Hour Allergy And Congestion | US5578610 | Piperidine derivatives |
Nov 26, 2013
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
Allegra-d 12 Hour Allergy And Congestion |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
Allegra-d 24 Hour Allergy And Congestion |
US6187791 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
Allegra-d 24 Hour Allergy And Congestion |
US6399632 (Pediatric) | Method of providing an antihistaminic effect in a hepatically impaired patient |
Nov 11, 2012
(Expired) | Chattem Sanofi |
Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride's Family Patents
